M. Bouhassira

718 total citations
25 papers, 532 citations indexed

About

M. Bouhassira is a scholar working on Psychiatry and Mental health, General Health Professions and Clinical Psychology. According to data from OpenAlex, M. Bouhassira has authored 25 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 5 papers in General Health Professions and 5 papers in Clinical Psychology. Recurrent topics in M. Bouhassira's work include Schizophrenia research and treatment (5 papers), Obsessive-Compulsive Spectrum Disorders (4 papers) and Health, Medicine and Society (4 papers). M. Bouhassira is often cited by papers focused on Schizophrenia research and treatment (5 papers), Obsessive-Compulsive Spectrum Disorders (4 papers) and Health, Medicine and Society (4 papers). M. Bouhassira collaborates with scholars based in France, Belgium and Belize. M. Bouhassira's co-authors include Sylvie Lancrenon, Y. Lecrubier, Patrick Blin, I. Gasquet, A Fourrier, Bernard Bégaud, J.P. Lépine, Élie Hantouche, Jean‐Pierre Olié and D. Attar-Lèvy and has published in prestigious journals such as The British Journal of Psychiatry, Journal of Affective Disorders and Psychiatry Research.

In The Last Decade

M. Bouhassira

25 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Bouhassira France 13 262 148 94 89 84 25 532
David Raft United States 16 185 0.7× 231 1.6× 122 1.3× 58 0.7× 77 0.9× 37 705
Basil G. Bereza Canada 15 83 0.3× 156 1.1× 73 0.8× 69 0.8× 29 0.3× 22 556
Erica C.G. van Geffen Netherlands 14 127 0.5× 97 0.7× 69 0.7× 60 0.7× 25 0.3× 20 580
Hiram Joseph Wildgust United Kingdom 13 436 1.7× 85 0.6× 91 1.0× 42 0.5× 27 0.3× 18 734
Mathias Riesbeck Germany 14 510 1.9× 60 0.4× 192 2.0× 68 0.8× 139 1.7× 27 732
E Guillibert France 6 184 0.7× 95 0.6× 53 0.6× 53 0.6× 84 1.0× 12 376
Charlene Bryan United States 13 102 0.4× 78 0.5× 58 0.6× 71 0.8× 77 0.9× 17 525
Nicolas Despiégel France 17 151 0.6× 302 2.0× 71 0.8× 188 2.1× 46 0.5× 38 698
I. Kurzthaler Austria 15 462 1.8× 126 0.9× 97 1.0× 47 0.5× 15 0.2× 31 704
Miranda Kim United Kingdom 7 319 1.2× 57 0.4× 62 0.7× 14 0.2× 33 0.4× 9 602

Countries citing papers authored by M. Bouhassira

Since Specialization
Citations

This map shows the geographic impact of M. Bouhassira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bouhassira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bouhassira more than expected).

Fields of papers citing papers by M. Bouhassira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bouhassira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bouhassira. The network helps show where M. Bouhassira may publish in the future.

Co-authorship network of co-authors of M. Bouhassira

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bouhassira. A scholar is included among the top collaborators of M. Bouhassira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bouhassira. M. Bouhassira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aubert, Jean‐Pierre, Pascale Massin, S. Bouée, et al.. (2007). [Evaluation of a screening programme for diabetic retinopathy (DODIA study)].. PubMed. 57(11). 1203–9. 2 indexed citations
3.
França, Lionel Riou, R Launois, K Le Lay, et al.. (2006). Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis with multiple organ failure. International Journal of Technology Assessment in Health Care. 22(1). 101–108. 21 indexed citations
4.
Massin, Pascale, É. Eschwège, Ali Erginay, et al.. (2005). Evaluation of a screening program for diabetic retinopathy in a primary care setting Dodia (Dépistage ophtalmologique du diabète) study. Diabetes & Metabolism. 31(2). 153–162. 28 indexed citations
5.
Gasquet, I., et al.. (2001). Déterminants de l'observance thérapeutique des antidépresseurs. 27(1). 83–91. 4 indexed citations
6.
Fourrier, A, et al.. (2000). Patterns of neuroleptic drug prescription: a national cross‐sectional survey of a random sample of French psychiatrists. British Journal of Clinical Pharmacology. 49(1). 80–86. 63 indexed citations
7.
Sarfati, Yves, et al.. (2000). [New antipsychotics in the treatment of schizophrenia. A European survey].. PubMed. 25(6). 658–66. 15 indexed citations
8.
Guelfi, J, et al.. (1999). [The study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients followed in general practice].. PubMed. 25(3). 265–70. 19 indexed citations
9.
Blin, Patrick, et al.. (1999). [Use of a structured diagnostic interview to identify depressive episodes in an epidemiologic study: a posteriori internal validation].. PubMed. 47(5). 455–63. 31 indexed citations
10.
Lecrubier, Y., et al.. (1999). Olanzapine versus amisulpride and placebo in the treatment of negative symptoms and deficit states of chronic schizophrenia. European Neuropsychopharmacology. 9. 288–288. 13 indexed citations
11.
Mentré, France, et al.. (1998). Relationships between low red blood cell count and clinical response to fluoxetine in depressed elderly patients. Psychiatry Research. 81(3). 403–405. 2 indexed citations
12.
Bouhassira, M., et al.. (1998). Which patients receive antidepressants? A `real world' telephone study. Journal of Affective Disorders. 49(1). 19–26. 25 indexed citations
13.
Vanelle, Jean‐Marie, D. Attar-Lèvy, Marie‐France Poirier, et al.. (1997). Controlled efficacy study of fluoxetine in dysthymia. The British Journal of Psychiatry. 170(4). 345–350. 47 indexed citations
14.
Hantouche, Élie, et al.. (1997). [Repeat evaluation of impulsiveness in a cohort of 155 patients with obsessive-compulsive disorder: 12 months prospective follow-up].. PubMed. 23(2). 83–90. 6 indexed citations
15.
Hantouche, Élie, M. Bourgeois, M. Bouhassira, & Sylvie Lancrenon. (1997). [Clinical aspects of obsessive-compulsive syndromes: results of phase 2 of a large French survey].. PubMed. 22(4). 255–63. 1 indexed citations
16.
Charpak, Yves, et al.. (1997). [Cohort study of treated or not treated depressive workers: methodology and preliminary results].. PubMed. 51(4). 358–60. 1 indexed citations
17.
Hantouche, Élie, et al.. (1996). [Prevalence of obsessive-compulsive disorders in a large French patient population in psychiatric consultation].. PubMed. 21(5). 571–80. 17 indexed citations
18.
Rouillon, F., et al.. (1996). [Pharmaco-epidemiologic study of the use of antidepressant drugs in the general population].. PubMed. 22 Spec No 1. 39–48. 7 indexed citations
19.
Razavi, Darius, J.‐F. Allilaire, Mark A. Smith, et al.. (1996). The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatrica Scandinavica. 94(3). 205–210. 128 indexed citations
20.
Daléry, J, et al.. (1995). [Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine].. PubMed. 21(3). 217–25. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026